Fortress Biotech, Inc. (FBIO) 13D/13G Filings for Checkpoint Therapeutics, Inc. (CKPT)

Fortress Biotech, Inc. 13D and 13G filings for Checkpoint Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-06-03
6:46 pm
Sale
2025-05-3013DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
0
0.000%
-6,922,249decrease
(Position Closed)
Filing
2025-03-11
4:29 pm
Purchase
2025-03-0913DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
6,922,249
11.200%
18,500increase
(+0.27%)
Filing
2025-01-03
6:26 pm
Purchase
2024-12-3113DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
6,903,749
13.500%
2,468,215increase
(+55.65%)
Filing
2024-10-01
4:15 pm
Purchase
2024-09-2713DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
4,435,534
9.800%
146,341increase
(+3.41%)
Filing
2024-05-17
5:13 pm
Purchase
2024-05-1613DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
4,289,193
11.200%
1,492,915increase
(+53.39%)
Filing
2024-03-22
6:24 pm
Purchase
2024-03-2013DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
2,796,278
7.500%
352,039increase
(+14.40%)
Filing
2023-09-26
4:16 pm
Purchase
2023-09-2513DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
2,444,239
11.300%
80,906increase
(+3.42%)
Filing
2023-07-06
4:44 pm
Purchase
2023-06-3013DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
2,363,333
13.600%
81,406increase
(+3.57%)
Filing
2023-04-19
4:24 pm
Purchase
2023-03-3113DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
2,281,927
17.500%
78,214increase
(+3.55%)
Filing
2023-01-13
4:13 pm
Purchase
2023-01-0513DCHECKPOINT THERAPEUTICS INC CO
CKPT
Fortress Biotech, Inc.
FBIO
2,203,713
19.300%
1,060,161increase
(+92.71%)
Filing